BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35876044)

  • 1. Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma.
    Nguyen MV; Walia A; Saidian A; Puri D; Meagher MF; Hakimi K; Tanaka H; Patil D; Yasuda Y; Saito K; Dhanji S; Cerrato C; Narasimhan R; Perry J; Master V; Fujii Y; Derweesh IH
    BJU Int; 2023 Feb; 131(2):219-226. PubMed ID: 35876044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
    Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH
    BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.
    Saitta C; Garofano G; Lughezzani G; Meagher MF; Yuen KL; Fasulo V; Diana P; Uleri A; Piccolini A; Mancon S; Arena P; Sordelli F; Mantovani M; Avolio PP; Beatrici E; Hurle RF; Lazzeri M; Saita A; Casale P; Derweesh IH; Paciotti M; Buffi NM
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541189
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of functional outcome of bilateral kidney tumors after sequential surgery.
    Kim JK; Kim H; Lee H; Oh JJ; Lee S; Hong SK; Kwak C; Byun SS
    BMC Cancer; 2021 May; 21(1):592. PubMed ID: 34024273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR.
    Yuan JH; Tanaka H; Patil D; Hakimi K; Soliman S; Meagher MF; Saidian A; Walia A; Dhanji S; Liu F; Afari J; Nguyen M; Wang L; Yasuda Y; Saito K; Fujii Y; Master V; Derweesh IH
    Clin Genitourin Cancer; 2023 Aug; 21(4):e219-e227. PubMed ID: 36588000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis.
    Saitta C; Afari JA; Autorino R; Capitanio U; Porpiglia F; Amparore D; Piramide F; Cerrato C; Meagher MF; Noyes SL; Pandolfo SD; Buffi NM; Larcher A; Hakimi K; Nguyen MV; Puri D; Diana P; Fasulo V; Saita A; Lughezzani G; Casale P; Antonelli A; Montorsi F; Lane BR; Derweesh IH
    Urol Oncol; 2023 Dec; 41(12):487.e15-487.e23. PubMed ID: 37880003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.
    Hamilton ZA; Capitanio U; Lane BR; Larcher A; Yim K; Dey S; Cotta BH; Meagher MF; Kirmiz S; Bezinque A; Eldefrawy A; Bradshaw A; Ryan S; Carenzi C; Wan F; Proudfoot J; Montorsi F; Derweesh IH
    World J Urol; 2019 Nov; 37(11):2429-2437. PubMed ID: 30710156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery.
    Wu J; Suk-Ouichai C; Dong W; Antonio EC; Derweesh IH; Lane BR; Demirjian S; Li J; Campbell SC
    BJU Int; 2018 Jan; 121(1):93-100. PubMed ID: 28834125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
    BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
    Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
    Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
    Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
    Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.
    McIntosh AG; Parker DC; Egleston BL; Uzzo RG; Haseebuddin M; Joshi SS; Viterbo R; Greenberg RE; Chen DYT; Smaldone MC; Kutikov A
    BJU Int; 2019 Dec; 124(6):999-1005. PubMed ID: 31145523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma.
    Kim YW; Kim WT; Yun SJ; Lee SC; Kim WJ; Ha YS; Park YH; Kang SH; Hong SH; Kwon TG; Byun SS; Kwak C; Kim YJ
    Ann Surg Oncol; 2015 Nov; 22(12):4098-103. PubMed ID: 25851339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate.
    Chung JS; Son NH; Lee SE; Hong SK; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
    J Korean Med Sci; 2018 Oct; 33(43):e277. PubMed ID: 30344463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial nephrectomy vs. radical nephrectomy for stage I renal cell carcinoma in the presence of predisposing systemic diseases for chronic kidney disease.
    Demir Ö; Bozkurt O; Çelik S; Çömez K; Aslan G; Mungan U; Çelebi İ; Esen A
    Kaohsiung J Med Sci; 2017 Jul; 33(7):339-343. PubMed ID: 28738974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of short warm ischemic time on longitudinal kidney function and survival rate after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease stage III: A multi-institutional propensity score-matched study.
    Chung JS; Hong SK; Lee SC; Jeong CW; Kwak C; Kim HH; Hong SH; Kim YJ; Kang SH; Chung J; Kwon TG; Hwang EC; Byun SS
    Eur J Surg Oncol; 2021 Feb; 47(2):470-476. PubMed ID: 32631709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
    Palacios DA; Zabor EC; Munoz-Lopez C; Roversi G; Mahmood F; Abramczyk E; Kelly M; Wilson B; Abouassaly R; Campbell SC
    Eur Urol; 2021 Jun; 79(6):774-780. PubMed ID: 33678521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.